Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2nvd | ITB | Aldose reductase | 1.1.1.21 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
2nvd | ITB | Aldose reductase | 1.1.1.21 | 1.000 | |
1az1 | ALR | Aldose reductase | 1.1.1.21 | 0.548 | |
4q0k | GA3 | Phytohormone-binding protein | / | 0.500 | |
1r5g | AO1 | Methionine aminopeptidase 2 | / | 0.485 | |
2bf4 | FMN | NADPH--cytochrome P450 reductase | / | 0.481 | |
1yw9 | A84 | Methionine aminopeptidase 2 | / | 0.477 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.475 | |
3qe2 | FMN | NADPH--cytochrome P450 reductase | / | 0.473 | |
1dx6 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.472 | |
1fap | RAP | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.471 | |
1fap | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.471 | |
2ea4 | F79 | Methionine aminopeptidase 2 | / | 0.469 | |
4psb | GA3 | Cytokinin-specific binding protein | / | 0.469 | |
4tnz | TTP | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 3.1.5 | 0.469 | |
1v3q | 2DI | Purine nucleoside phosphorylase | 2.4.2.1 | 0.466 | |
2gv8 | NDP | Thiol-specific monooxygenase | 1.14.13 | 0.462 | |
3hl0 | NAD | Maleylacetate reductase | / | 0.462 | |
4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.461 | |
1eve | E20 | Acetylcholinesterase | 3.1.1.7 | 0.459 | |
1nqu | RDL | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.459 | |
2ipw | 2CL | Aldose reductase | 1.1.1.21 | 0.459 | |
4mr7 | 2BV | Gamma-aminobutyric acid type B receptor subunit 1 | / | 0.459 | |
2pdk | SBI | Aldose reductase | 1.1.1.21 | 0.458 | |
1ps9 | MDE | 2,4-dienoyl-CoA reductase | 1.3.1.34 | 0.457 | |
1w6r | GNT | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
2fap | RAD | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.457 | |
2fap | RAD | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.457 | |
3ug8 | IMN | Aldo-keto reductase family 1 member C3 | / | 0.454 | |
1qti | GNT | Acetylcholinesterase | 3.1.1.7 | 0.453 | |
2a58 | RBF | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.453 | |
2wzy | SQX | Soluble acetylcholine receptor | / | 0.453 | |
3bw2 | FMN | Putative 2-nitropropane dioxygenase | / | 0.453 | |
4c5o | FAD | Putative monooxygenase | / | 0.453 | |
2whq | HI6 | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
3bw4 | FMN | Putative 2-nitropropane dioxygenase | / | 0.452 | |
1yci | NDF | Hypoxia-inducible factor 1-alpha inhibitor | 1.14.11.30 | 0.451 | |
2q1s | NAI | Putative nucleotide sugar epimerase/ dehydratase | / | 0.451 | |
3dyl | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.451 | |
3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.451 | |
4drj | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.451 | |
4drj | RAP | Peptidyl-prolyl cis-trans isomerase FKBP4 | 5.2.1.8 | 0.451 | |
1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.450 | |
2a3b | CFF | Endochitinase B1 | 3.2.1.14 | 0.450 | |
2ga2 | A19 | Methionine aminopeptidase 2 | / | 0.450 | |
1gpn | HUB | Acetylcholinesterase | 3.1.1.7 | 0.449 | |
1nup | NMN | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 | / | 0.449 | |
2jf0 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.449 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.448 | |
1tco | FK5 | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.448 | |
1tco | FK5 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 3.1.3.16 | 0.448 | |
1jg0 | DDT | Thymidylate synthase | / | 0.446 | |
5ao1 | DG3 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 3.1.5 | 0.446 | |
4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.445 | |
4dri | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.445 | |
4dri | RAP | Peptidyl-prolyl cis-trans isomerase FKBP5 | 5.2.1.8 | 0.445 | |
2pk3 | A2R | GDP-6-deoxy-D-mannose reductase | / | 0.444 | |
3dys | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.444 | |
4bfy | ZVY | Pantothenate kinase | 2.7.1.33 | 0.444 | |
4hcy | 0YN | Transketolase | / | 0.444 | |
4m0f | 1YK | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
1ddu | DDU | Thymidylate synthase | / | 0.443 | |
2g1s | 4IG | Renin | 3.4.23.15 | 0.443 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.443 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
4lrr | CF9 | Thymidylate synthase | / | 0.443 | |
4mrm | 2BY | Gamma-aminobutyric acid type B receptor subunit 1 | / | 0.443 | |
1q5m | NDP | Prostaglandin-E(2) 9-reductase | 1.1.1.189 | 0.442 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.442 | |
1ddu | CB3 | Thymidylate synthase | / | 0.441 | |
1odc | A8B | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
1q13 | TES | Prostaglandin-E(2) 9-reductase | 1.1.1.189 | 0.441 | |
2bn4 | FMN | NADPH--cytochrome P450 reductase | / | 0.441 | |
2v2z | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | / | 0.441 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
3dyq | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
3u5y | SCG | Raucaffricine-O-beta-D-glucosidase | 3.2.1.125 | 0.441 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
4b5n | FMN | NAD(P)H:flavin oxidoreductase Sye4 | / | 0.441 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.441 | |
4gdd | NAI | UDP-galactopyranose mutase | / | 0.441 | |
1c7o | PPG | Hemolysin | / | 0.440 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
4rxq | DUT | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 3.1.5 | 0.440 |